YDESW NASDAQ
YD Bio Limited Warrants
1W: +27.3%
1M: +62.2%
3M: +128.1%
YTD: -36.5%
1Y: -60.5%
$0.67
-0.06 (-8.06%)
Weekly Expected Move ±29.7%
$0
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.2M
52W Range0.1904-2.5
Volume44,349
Avg Volume12,860
Beta-0.13
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOEthan Shen
Employees15
SectorHealthcare
IndustryBiotechnology
IPO Date2025-08-29
Websiteydesgroup.com
No. 3, Xingnan St.
Taipei, TP 115001
TW
Taipei, TP 115001
TW
+852 3590 6121
About YD Bio Limited Warrants
YD Bio Limited specializes in pioneering diagnostic and therapeutic technologies. Its offerings encompass oncology screening solutions, regenerative treatments for ophthalmology, and advancements in exosome research. Established on February 6, 2024, the firm is based in Taipei, Taiwan.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Lu Shao-Ta | A-Award | 2,081 | — | 2026-03-31 |
| Lu Shao-Ta | M-Exempt | 2,081 | — | 2026-03-31 |
| Chang Kochi | A-Award | 2,081 | — | 2026-03-31 |
| Chang Kochi | M-Exempt | 2,081 | — | 2026-03-31 |
| Lu Shao-Ta | 0 | — | 2026-03-18 |